Cadherin 5 is a single-pass transmembrane protein that mediates calcium-dependent cell-cell adhesion. It has five extracellular cadherin domains that facilitate homophilic interactions between adjacent endothelial cells . These interactions are vital for the formation of adherens junctions, which are necessary for the stability and permeability of blood vessels.
The protein is encoded by the CDH5 gene, which is located on chromosome 16 in humans . The gene is highly conserved across species, indicating its essential role in vascular biology.
Cadherin 5 is involved in various biological processes, including:
Cadherin 5 has been studied extensively for its role in various diseases, particularly cancer. It has been identified as a biomarker for metastatic breast cancer, especially in estrogen receptor-positive cancers with vascular invasion . Elevated levels of Cadherin 5 and its glycosylation status have been associated with poor prognosis in breast cancer patients .
Additionally, mutations or dysregulation of the CDH5 gene can lead to vascular defects and contribute to the development of various cardiovascular diseases .
Recombinant Cadherin 5 (Human) is produced using recombinant DNA technology, which involves inserting the human CDH5 gene into a suitable expression system, such as bacteria or mammalian cells. This allows for the large-scale production of the protein for research and therapeutic purposes.
Recombinant Cadherin 5 is used in various applications, including:
In conclusion, Cadherin 5 (Human Recombinant) is a vital protein with significant roles in vascular biology and disease. Its recombinant form provides valuable tools for research, diagnostics, and therapeutic development.